These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25863110)

  • 1. Study of FibroTest and hyaluronic acid biological variation in healthy volunteers and comparison of serum hyaluronic acid biological variation between chronic liver diseases of different etiology and fibrotic stage using confidence intervals.
    Istaces N; Gulbis B
    Clin Biochem; 2015 Jul; 48(10-11):652-7. PubMed ID: 25863110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis.
    Rossi E; Adams LA; Ching HL; Bulsara M; MacQuillan GC; Jeffrey GP
    Clin Chem Lab Med; 2013 May; 51(5):1107-14. PubMed ID: 23152415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
    Stibbe KJ; Verveer C; Francke J; Hansen BE; Zondervan PE; Kuipers EJ; de Knegt RJ; van Vuuren AJ
    Scand J Gastroenterol; 2011 Jul; 46(7-8):962-72. PubMed ID: 21623677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease.
    Cassinotto C; Lapuyade B; Aït-Ali A; Vergniol J; Gaye D; Foucher J; Bailacq-Auder C; Chermak F; Le Bail B; de Lédinghen V
    Radiology; 2013 Oct; 269(1):283-92. PubMed ID: 23630312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.
    Naveau S; Raynard B; Ratziu V; Abella A; Imbert-Bismut F; Messous D; Beuzen F; Capron F; Thabut D; Munteanu M; Chaput JC; Poynard T
    Clin Gastroenterol Hepatol; 2005 Feb; 3(2):167-74. PubMed ID: 15704051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced liver fibrosis (ELF) score: Reference ranges, biological variation in healthy subjects, and analytical considerations.
    Jabor A; Kubíček Z; Fraňková S; Šenkeříková R; Franeková J
    Clin Chim Acta; 2018 Aug; 483():291-295. PubMed ID: 29772213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
    Halfon P; Munteanu M; Poynard T
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):22-39. PubMed ID: 18973844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hyaluronic acid as a marker of hepatic fibrosis.
    Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of reelin for assessing hepatic fibrogenesis in a group of Egyptian HCV infected patients.
    Mansy SS; Nosseir MM; Zoheiry MA; Hassanein MH; Guda MF; Othman MM; AbuTalab H
    Clin Chem Lab Med; 2014 Sep; 52(9):1319-28. PubMed ID: 24803609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid concentration in liver diseases.
    Gudowska M; Gruszewska E; Panasiuk A; Cylwik B; Flisiak R; Świderska M; Szmitkowski M; Chrostek L
    Clin Exp Med; 2016 Nov; 16(4):523-528. PubMed ID: 26354758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.
    Suzuki A; Angulo P; Lymp J; Li D; Satomura S; Lindor K
    Liver Int; 2005 Aug; 25(4):779-86. PubMed ID: 15998429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
    Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
    Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The noninvasive evaluation of degree of expression of fibrosis of liver and significance of polymorphism of gene of hyaluronic acid under chronic hepatitis C].
    Bulatova IA; Schekotova AP; Krivtsov AV; Schekotov VV; Pavlov AI
    Klin Lab Diagn; 2015 Mar; 60(3):18-21. PubMed ID: 26031159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hyaluronic acid as a predictor of fibrosis in chronic hepatitis B and C virus infection.
    Nath NC; Rahman MA; Khan MR; Hasan MS; Bhuiyan TM; Hoque MN; Kabir MM; Raha AK; Jahan B
    Mymensingh Med J; 2011 Oct; 20(4):614-9. PubMed ID: 22081179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].
    Iushchuk ND; Znoĭko OO; Safiullina NKh; Dudina KR; Kelli EI; Klimova EA; Kashirin VI; Braginskiĭ DM; Kushlinskiĭ NE; Liubimova NV; Vasilev AIu; Penkina TV; Danilin AG
    Ter Arkh; 2005; 77(4):50-5. PubMed ID: 15938533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.